Reboxetine improves motor function in chronic stroke-Reference-Cited by-同舟云学术

Reboxetine improves motor function in chronic stroke

Published:2007-02 Issue:2 Volume:254 Page:197-201
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Zittel Simone,Weiller Cornelius,Liepert Joachim

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-006-0326-5.pdf

Reference10 articles.

1. Broeks JG, Lankhorst GJ, Rumping K, Prevo AJ (1999) The long-term outcome of arm function after stroke: results of a follow-up study. Disabil Rehabil 21:357–364

2. Feeney DM, De Smet AM, Rai S (2004) Noradrenergic modulation o hemiplegia: Facilitation and maintenance of recovery. Restor Neurol Neurosci 22:175–190

3. Fleishaker JC (2000) Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. Clin Pharmacokinet 39:413–427

4. Herwig U, Bräuer K, Connemann B, Spitzer M, Schönfeldt-Lecuona C (2002) Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology 164:228–232

5. Kwakkel G, Wagenaar RC, Koelman TW, Lankhorst GJ, Koetsier JC (1997) Effects of intensity of rehabilitation after stroke. Stroke 28:1550–1556

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options;International Journal of Molecular Sciences;2024-07-16

2. Cerebral stroke-induced neurogenesis: insights and therapeutic implications;Exploration of Neuroprotective Therapy;2024-04-26

3. A systematic-search-and-review of registered pharmacological therapies investigated to improve neuro-recovery after a stroke;Frontiers in Neurology;2024-01-31

4. Serotonergic and noradrenergic contributions to motor cortical and spinal motoneuronal excitability in humans;Neuropharmacology;2024-01

5. Central Noradrenergic Agonists in the Treatment of Ischemic Stroke—an Overview;Translational Stroke Research;2019-07-20